Sign in
Not yet recruitingNo phase

Tissue Doppler Echocardiographic Assessment of Cardiac Function in Neonatal Sepsis

Key facts

Who runs it
Assiut University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
80 people, planned
Started
1 May 2026
Expected to end
1 May 2029
Type of study
Observational, 2 groups
Treatments tested
  • cardiac troponin, and blood culture
Record updated
7 May 2026

Who can take part

Age
1 day to 1 month
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • This study includes 2 groups
  • sepsis group include neonate e sepsis (both preterm and term neonate confirmed to have neonatal sepsis by positive sepsis markers (CBC, CRP, Blood culture))
  • control group include healthy group admitted for weight gain or jaundice) Babies on ventilators and non-invasive ventilation, septic shock are included in the study; -

Who cannot take part

  • Infants with other comorbidities as congenital malformations, genetic syndromes, congenital heart diseases, infants of diabetic mothers, infants with hypoxic ischemic encephalopathy (HIE) or critical CHDs will be excluded from the study
  • -

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

1. To assess myocardial function in neonates with sepsis using tissue doppler echocardiography. 2. To assess sepsis induced cardiac dysfunction. 3. To measure serum levels of sepsis markers (CBC,CRP,Blood culture) and cardiac troponin in neonatal sepsis. 4. To analyze the correlation between echocardiographic parameters and serum biomarkers. 5. To determine whether these echocardiographic techniques can serve as early predictors of cardiac involvement in neonatal sepsis.

The 2 groups in the trial

  • sepsis group include neonate with sepsis (both preterm and term neonate)

    confirmed to have neonatal sepsis by positive sepsis markers (CBC, CRP, Blood culture))

    Treatment: cardiac troponin, and blood culture

  • - control group include healthy group admitted for weight gain or jaundice)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Tissue Doppler Echocardiographic Assessment of Cardiac Function in Neonatal Sepsis and Correlation With Cardiac Troponin and Sepsis Biomarkers
Record updated
7 May 2026